These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9310479)

  • 1. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.
    Borge OJ; Ramsfjell V; Cui L; Jacobsen SE
    Blood; 1997 Sep; 90(6):2282-92. PubMed ID: 9310479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
    Petzer AL; Zandstra PW; Piret JM; Eaves CJ
    J Exp Med; 1996 Jun; 183(6):2551-8. PubMed ID: 8676076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
    Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
    Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
    Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
    J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
    Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
    Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal support augments extended long-term ex vivo expansion of hemopoietic progenitor cells.
    Kusadasi N; Koevoet JL; van Soest PL; Ploemacher RE
    Leukemia; 2001 Sep; 15(9):1347-58. PubMed ID: 11516095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.
    Ramsfjell V; Borge OJ; Veiby OP; Cardier J; Murphy MJ; Lyman SD; Lok S; Jacobsen SE
    Blood; 1996 Dec; 88(12):4481-92. PubMed ID: 8977240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34(+) cord blood cells in long-term serum-deprived liquid culture.
    Sawai N; Koike K; Ito S; Mwamtemi HH; Kurokawa Y; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Miyazaki H; Kato T; Komiyama A
    Blood; 1999 Jan; 93(2):509-18. PubMed ID: 9885212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of serum-free pre-colony forming unit assays for differentiation of primitive hematopoietic progenitors: serum induces early macrophage differentiation and inhibits early erythroid differentiation of CD34++CD38- cells.
    Willems R; Henckaerts E; Lenjou M; Nijs G; Rodrigus I; Moulijn AC; Slegers H; Berneman ZN; Van Bockstaele DR
    Ann Hematol; 2001 Jan; 80(1):17-25. PubMed ID: 11233770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells.
    Fan X; Brun A; Segrén S; Jacobsen SE; Karlsson S
    Hum Gene Ther; 2000 Jun; 11(9):1313-27. PubMed ID: 10890741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
    Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
    Xiao M; Oppenlander BK; Plunkett JM; Dooley DC
    Exp Hematol; 1999 May; 27(5):916-27. PubMed ID: 10340408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro.
    Shah AJ; Smogorzewska EM; Hannum C; Crooks GM
    Blood; 1996 May; 87(9):3563-70. PubMed ID: 8611678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand.
    Haylock DN; Horsfall MJ; Dowse TL; Ramshaw HS; Niutta S; Protopsaltis S; Peng L; Burrell C; Rappold I; Buhring HJ; Simmons PJ
    Blood; 1997 Sep; 90(6):2260-72. PubMed ID: 9310477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CD95/Fas and its ligand in the regulation of the growth of human CD34(++)CD38(-) fetal liver cells.
    Bárcena A; Muench MO; Song KS; Ohkubo T; Harrison MR
    Exp Hematol; 1999 Sep; 27(9):1428-39. PubMed ID: 10480434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.